Effectiveness and Safety of Combining Tofacitinib with a Biologic in Patients with Refractory Inflammatory Bowel Diseases

Quazim A. Alayo, Aava Khatiwada, Anish Patel, Maria Zulfiqar, Anas Gremida, Alexandra Gutierrez, Richard P. Rood, Matthew A. Ciorba, George Christophi, Parakkal Deepak
doi: https://doi.org/10.1101/2020.10.18.20214841

Article usage

Article usage: October 2020 to December 2024

AbstractFullPdf
Oct 20201881340
Nov 202030010564
Dec 2020588770
Jan 2021489040
Feb 20215710413
Mar 20215214045
Apr 20217514936
May 20218213831
Jun 20216411522
Jul 20214410947
Aug 20215210024
Sep 2021329628
Oct 2021276050
Nov 2021317043
Dec 2021336614
Jan 202214566
Feb 2022366126
Mar 2022288614
Apr 2022297515
May 2022227845
Jun 2022245516
Jul 2022187914
Aug 202223584
Sep 2022414518
Oct 2022295612
Nov 202213447
Dec 2022156512
Jan 2023237014
Feb 2023127716
Mar 20231810013
Apr 2023187913
May 2023167012
Jun 202322566
Jul 2023127517
Aug 2023186211
Sep 2023195910
Oct 20238574
Nov 202316681
Dec 202315277
Jan 20249348
Feb 2024164510
Mar 202484419
Apr 202493118
May 202443512
Jun 2024132811
Jul 202412269
Aug 2024133413
Sep 2024112612
Oct 20248447
Nov 2024141510
Dec 20244127
Back to top
Posted October 21, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness and Safety of Combining Tofacitinib with a Biologic in Patients with Refractory Inflammatory Bowel Diseases
Quazim A. Alayo, Aava Khatiwada, Anish Patel, Maria Zulfiqar, Anas Gremida, Alexandra Gutierrez, Richard P. Rood, Matthew A. Ciorba, George Christophi, Parakkal Deepak
medRxiv 2020.10.18.20214841; doi: https://doi.org/10.1101/2020.10.18.20214841
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area